The association between neopterin and acetaminophen-induced nephrotoxicity

Renal Failure

Volumn 32, Issue 6, 2010, Pages 740-746

  Cakir, Erdinc ^a   Akgul, Ozgur E ^a   Aydin, Ibrahim ^a   Cayci, Tuncer ^a   Kurt, Yasemin Gulcan ^a   Onguru, Onder ^a   Aydin, Fevzi N ^a   Agilli, Mehmet ^a   Yaman, Halil ^a   Ersoz, Nail ^a   Bilgic, Serkan ^a   Guven, Ahmet ^a   Turker, Turker ^a   Bilgi, Cumhur ^a   Erbil, Kemal M ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acetaminophen; Marker; Neopterin; Nephrotoxicity; Renal damage

Indexed keywords

BIOLOGICAL MARKER; CREATININE; NEOPTERIN; PARACETAMOL; POTASSIUM; SODIUM; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG OVERDOSE; HISTOPATHOLOGY; KIDNEY INJURY; KIDNEY TUBULE DAMAGE; KIDNEY TUBULE NECROSIS; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; SINGLE DRUG DOSE; TISSUE LEVEL; WISTAR RAT;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; BIOLOGICAL MARKERS; KIDNEY; KIDNEY DISEASES; MALE; NEOPTERIN; RATS; RATS, WISTAR;

EID: 77953552573     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.486500     Document Type: Article

References (44)

1. Tan HH, Chang CY, Martin P. Acetaminophen hepatotoxicity: Current management. Mt Sinai J Med. 2009;76:75-83.
2. Kanno S, Tomizawa A, Hiura T, et al. Melatonin protects on toxicity by acetaminophen but not on pharmacological effects in mice. Biol Pharm Bull. 2006;29:472-476.
3. Hawton K, Fagg J. Trends in deliberate self poisoning and self injury in Oxford, 1976-1990. BMJ. 1992;304:1409-1411.
4. Daly FF, Fountain JS, Murray L, Graudins A, Buckley NA. Guidelines for the management of paracetamol poisoning in Australia and New Zealand - explanation and elaboration. Med J Aust. 2008;188:296-301.
5. Hart SG, Beierschmitt WP, Wyand DS, Khairallah EA, Cohen SD. Acetaminophen nephrotoxicity in CD-1 mice. I. Evidence of a role for in situ activation in selective covalent binding and toxicity. Toxicol Appl Pharmacol. 1994;126:267-275.
6. Mazer M, Perrone J. Acetaminophen-induced nephrotoxicity: Pathophysiology, clinical manifestations, and management. J Med Toxicol. 2008;4:2-6.
7. Prescott LF. Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs. 1983;25:290-314.
8. Boyer TD, Rouff SL. Acetaminophen-induced hepatic necrosis and renal failure. JAMA. 1971;218:440-444.
9. Nauta AJ, de Haij S, Bottazzi B, et al. Human renal epithelial cells produce the long pentraxin PTX3. Kidney Int. 2005;67:543-553.
10. Jones AF, Vale JA. Paracetamol poisoning and the kidney. J Clin Pharm Ther. 1993;18:5-8.
11. Eguia L, Materson BJ. Acetaminophen-related acute renal failure without fulminant liver failure. Pharmacotherapy. 1997;17:363-370.
12. Curry RW Jr, Robinson JD, Sughrue MJ. Acute renal failure after acetaminophen ingestion. JAMA. 1982;247:1012-1014.
13. Kleinman JG, Breitenfield RV, Roth DA. Acute renal failure associated with acetaminophen ingestion: Report of a case and review of the literature. Clin Nephrol. 1980;14:201-205.
14. Kher K, Makker S. Acute renal failure due to acetaminophen ingestion without concurrent hepatotoxicity. Am J Med. 1987;82:1280-1281.
15. Cobden I, Record CO, Ward MK, Kerr DN. Paracetamolinduced acute renal failure in the absence of fulminant liver damage. Br Med J (Clin Res Ed). 1982;284:21-22.
16. Blakely P, McDonald BR. Acute renal failure due to acetaminophen ingestion: A case report and review of the literature. J Am Soc Nephrol. 1995;6:48-53.
17. Hart SG, Cartun RW, Wyand DS, Khairallah EA, Cohen SD. Immunohistochemical localization of acetaminophen in target tissues of the CD-1 mouse: Correspondence of covalent binding with toxicity. Fundam Appl Toxicol. 1995;24:260-274.
18. Jones AL, Prescott LF. Unusual complications of paracetamol poisoning. QJM. 1997;90:161-168.
19. Muller MM, Curtius HC, Herold M, Huber CH. Neopterin in clinical practice. Clin Chim Acta. 1991;201:1-16.
20. Ruokonen E, Ilkka L, Niskanen M, Takala J. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand. 2002;46:398-404.
21. Huber C, Batchelor JR, Fuchs D, et al. Immune responseassociated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med. 1984;160:310-316.
22. Turgan N, Habif S, Parildar Z, et al. Association between homocysteine and neopterin in healthy subjects measured by a simple HPLC-fluorometric method. Clin Biochem. 2001; 34:271-275.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
24. Chatterjee PK, Patel NS, Kvale EO, et al. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int. 2002;61:862-871.
25. Alrashed M, Abougoush M, Akgul EO, et al. Detection method of serum and urine neopterin levels by high performance liquid chromatography and clinical applications. Gulhane MJ. 2002;44:273-277 [Article in Turkish].
26. Houghton DC, Plamp CE III, DeFehr JM, Bennett WM, Porter G, Gilbert D. Gentamicin and tobramycin nephrotoxicity. A morphologic and functional comparison in the rat. Am J Pathol. 1978;93:137-152.
27. Pakravan N, Simpson KJ, Waring WS, Bates CM, Bateman DN. Renal injury at first presentation as a predictor for poor outcome in severe paracetamol poisoning referred to a liver transplant unit. Eur J Clin Pharmacol. 2009;65:163-168.
28. Prescott LF, Roscoe P, Wright N, Brown SS. Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet. 1971;1:519-522.
29. Mitchell JR, Jollow DJ, Potter WZ, Davis DC, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther. 1973;187: 185-194.
30. McMurtry RJ, Snodgrass WR, Mitchell JR. Renal necrosis, glutathione depletion, and covalent binding after acetaminophen. Toxicol Appl Pharmacol. 1978;46:87-100.
31. Tarloff JB, Goldstein RS, Hook JB. Strain differences in acetaminophen nephrotoxicity in rats: Role of pharmacokinetics. Toxicology. 1989;56:167-177.
32. Trumper L, Girardi G, Elías MM. Acetaminophen nephrotoxicity in male Wistar rats. Arch Toxicol. 1992;66:107-111.
33. Gardner CR, Laskin JD, Dambach DM, et al. Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: Potential role of tumor necrosis factor-alpha and interleukin-10. Toxicol Appl Pharmacol. 2002;184:27-36.
34. Trumper L, Monasterolo LA, Elías MM. Probenecid protects against In vivo acetaminophen-induced nephrotoxicity in male Wistar rats. J Pharmacol Exp Ther. 1998;284:606-610.
35. Abraham P. Vitamin C may be beneficial in the prevention of paracetamol-induced renal damage. Clin Exp Nephrol. 2005;9:24-30.
36. Li C, Liu J, Saavedra JE, Keefer LK, Waalkes MP. The nitric oxide donor, V-PYRRO/NO, protects against acetaminopheninduced nephrotoxicity in mice. Toxicology. 2003;189:173-180. (Pubitemid 36773853)
37. Abdel-Zaher AO, Abdel-Hady RH, Mahmoud MM, Farrag MM. The potential protective role of alpha-lipoic acid against acetaminophen-induced hepatic and renal damage. Toxicology. 2008;243:261-270.
38. Blazka ME, Wilmer JL, Holladay SD, Wilson RE, Luster MI. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol. 1995;133:43-52.
39. Ishida Y, Kondo T, Tsuneyama K, Lu P, Takayasu T, Mukaida N. The pathogenic roles of tumor necrosis factor receptor p55 in acetaminophen-induced liver injury in mice. J Leukoc Biol. 2004;75:59-67.
40. James LP, Kurten RC, Lamps LW, McCullough S, Hinson JA. Tumour necrosis factor receptor 1 and hepatocyte regeneration in acetaminophen toxicity: A kinetic study of proliferating cell nuclear antigen and cytokine expression. Basic Clin Pharmacol Toxicol. 2005;97:8-14.
41. Ishida Y, Kondo T, Ohshima T, Fujiwara H, Iwakura Y, Mukaida N. A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J. 2002;16:1227-1236.
42. Masubuchi Y, Bourdi M, Reilly TP, Graf ML, George JW, Pohl LR. Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochem Biophys Res Commun. 2003;304:207-212.
43. Bourdi M, Masubuchi Y, Reilly TP, et al. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: Role of inducible nitric oxide synthase. Hepatology. 2002;35:289-298.
44. Sucher R, Schroecksnadel K, Weiss G, Margreiter R, Fuchs D, Brandacher G. Neopterin, a prognostic marker in human malignancies. Cancer Lett. 2010;287:13-22.